Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FCRL3 - Chronic lymphocytic leukemia cells response to the neutralization of inhibitor of apoptosis proteins
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FCRL3 - miR-193b overexpression effect on pancreatic cell line
FCRL3 - IGHV mutated/unmutated Mantle Cell Lymphoma patients: B cell lymphocytes
FCRL3 - Programmed Death-1-expressing CD8 T cells in healthy adult peripheral blood
FCRL3 - Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood
FCRL3 - Nasopharyngeal carcinoma
FCRL3 - Chronic lymphocytic leukemia: peripheral blood B cells (HG-U133B)
GEO DataSets Gene Chromosome neighbors Homologene neighbors
FCRL3 - Recombinant Interferon α effect on natural killer cells in vitro
FCRL3 - Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy effect on chronic lymphocytic leukemia
FCRL3 - Atherosclerotic left anterior descendent coronary artery: high scan
FCRL3 - Nodular lymphocyte-predominant Hodgkin lymphoma: lymphocytic and histiocytic cells
FCRL3 - Rheumatoid arthritic synovium response to tocilizumab
FCRL3 - Non-Hodgkin’s lymphoma cell lines response to antibodies against CD20 or B-cell receptor
FCRL3 - Follicular lymphoma and higher grade diffuse large B-cell lymphoma patients: lymph node tumor biopsies
FCRL3 - Breast cancer metastases from different anatomical sites: fine-needle aspiration biopsies
FCRL3 - Chronic lymphocytic leukemia with chromosomal deletion 11q: peripheral blood CD19+ cells
FCRL3 - Chronic lymphocytic leukemia: peripheral blood, bone marrow and lymph node matched samples
FCRL3 - Subcutaneous Interferon-beta-1b treatment in relapsing-remitting multiple sclerosis (U133 B): peripheral mononuclear blood cells
FCRL3 - Diabetic children: peripheral blood mononuclear cells (U133B)
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on